Format

Send to:

Choose Destination
See comment in PubMed Commons below
Genes Dev. 1998 Sep 1;12(17):2658-63.

JNK targets p53 ubiquitination and degradation in nonstressed cells.

Author information

  • 1The Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, New York 10029, USA.

Abstract

In this study we elucidated the role of nonactive JNK in regulating p53 stability. The amount of p53-JNK complex was inversely correlated with p53 level. A peptide corresponding to the JNK binding site on p53 efficiently blocked ubiquitination of p53. Similarly, p53 lacking the JNK binding site exhibits a longer half-life than p53(wt). Outcompeting JNK association with p53 increased the level of p53, whereas overexpression of a phosphorylation mutant form of JNK inhibited p53 accumulation. JNK-p53 and Mdm2-p53 complexes were preferentially found in G0/G1 and S/G2M phases of the cell cycle, respectively. Altogether, these data indicate that JNK is an Mdm2-independent regulator of p53 stability in nonstressed cells.

PMID:
9732264
[PubMed - indexed for MEDLINE]
PMCID:
PMC317120
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk